Outcomes in 1096 patients with severe thrombotic thrombocytopenic purpura before the Caplacizumab era.

Outcomes in 1096 patients with severe thrombotic thrombocytopenic purpura before the Caplacizumab era.

<h4>Introduction</h4>Thrombotic thrombocytopenic purpura (TTP) is a diagnostic and therapeutic emergency. Therapeutic plasma exchange (TPE) combined with immunosuppression has been the cornerstone of the initial management. To produce optimal benefits, emerging treatments must be used ag...

Full description

Bibliographic Details
Main Authors: Andry Van de Louw, Eric Mariotte, Michael Darmon, Austin Cohrs, Douglas Leslie, Elie Azoulay
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0256024

Internet

https://doi.org/10.1371/journal.pone.0256024

Similar Items